Header Logo

Connection

KIM-ANH DO to Imidazoles

Back to Details
This is a "connection" page, showing publications KIM-ANH DO has written about Imidazoles.
KIM-ANH DO
Connection Strength
0.083
Imidazoles
  1. Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma. Cancer. 2006 Aug 01; 107(3):497-505.
    View in: PubMed
    Score: 0.047
  2. MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma. 2022 12; 63(13):3154-3164.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.